Longboard Pharmaceuticals Inc (LBPH) PT Raised to $60 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts LBPH Hot Sheet
Price: $59.98 --0%
Rating Summary:
3 Buy, 6 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Rating Summary:
3 Buy, 6 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Join SI Premium – FREE
H.C. Wainwright analyst Patrick Trucchio raised the price target on Longboard Pharmaceuticals Inc (NASDAQ: LBPH) to $60.00 (from $25.00) while maintaining a Buy rating.
You May Also Be Interested In
- Goldman Sachs Upgrades Plains GP Holdings, L.P (PAGP) to Neutral
- MaxLinear (MXL) PT Raised to $105 at Stifel
- Nomura/Instinet Downgrades T&D Holdings Inc (8795:JP) (TDHOY) to Neutral
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
